BioNexus Gene Lab Corp (BGLC)
0.60
-0.01
(-1.57%)
USD |
NASDAQ |
May 03, 16:00
0.60
0.00 (0.00%)
After-Hours: 20:00
BioNexus Gene Lab Cash from Investing (TTM): -0.3826M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.3826M |
| September 30, 2023 | -0.4187M |
| June 30, 2023 | -0.0397M |
| March 31, 2023 | -0.2584M |
| December 31, 2022 | -0.4505M |
| September 30, 2022 | -0.4769M |
| June 30, 2022 | -0.5538M |
| March 31, 2022 | -0.3919M |
| December 31, 2021 | -0.4906M |
| Date | Value |
|---|---|
| September 30, 2021 | -0.8308M |
| June 30, 2021 | -0.7678M |
| March 31, 2021 | -0.6881M |
| December 31, 2020 | 1.32M |
| September 30, 2020 | 1.729M |
| June 30, 2020 | 1.728M |
| March 31, 2020 | 1.714M |
| December 31, 2019 | -0.0128M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.8308M
Minimum
Sep 2021
1.729M
Maximum
Sep 2020
0.0429M
Average
-0.3919M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
| Balchem Corp | -34.81M |
| Friedman Industries Inc | -12.96M |
| Solitario Resources Corp | -4.409M |
| Golden Minerals Co | 2.206M |
| Paramount Gold Nevada Corp | -0.1467M |